Nature Biotechnology 2006 John Ransom - Abstracts
| Nature Biotechnology 2006 John Ransom | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| A reprise for collaborative financing in biotech. | Business | John Ransom | |||
| Are small biotechs still underselling themselves? | Business | John Ransom | |||
| Deconstructing Myogen's market cap. | Business | John Ransom | |||
| Hedge funds gain edge by doubling biotech investment. | Business | John Ransom | |||
| Niche indications could drive higher valuations. | Business | John Ransom | |||
| Pipeline cherrypicking deal yields lucrative return.(new kinase inhibitors ) | Business | John Ransom | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.